[1]
Silva, M.F.D. et al. 2021. PATHOLOGICAL COMPLETE RESPONSE IN 2,141 PATIENTS SUBMITTED TO NEOADJUVANT CHEMOTHERAPY IN A BREAST CANCER REFERENCE CENTER. Mastology. 31, (Aug. 2021), 87.